knowledge -WSS

knowledge

author：entertainment 2025-09-05 13:47:14 - browse：1771

Sammy Kimball for STAT

Can unicorns survive without data? Did biotech get over its skis? And what is going on at Biogen?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen’s boardroom scandal has roiled a company that was supposed to be entering a new era.

For more on what we cover, here’s the Laronde story; here’s the latest on Biogen; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： AstraZeneca challenges Medicare drug negotiation program

WSS

2024 GOP presidential candidates spar over abortion in debate

Feds fine Medicare Advantage plans for overcharging members

Trump used to be more articulate. What could explain the change?

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Why more medical students aren't specializing in primary care

Apellis safety probe of eye disease drug centers on injection needle

Wikipedia

knowledge

knowledge

Cancer drug shortages should be causing more outrage

Tuberculosis patients need more than just free medication

Medical records are filled with copy

Complete sequence of Y chromosome published for first time

Cancer drug shortages should be causing more outrage

'Brian's Song' at 50 still offers lessons about cancer for today

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA panel gives mixed vote on blood pressure devices

BioMarin wins approval for gene therapy to treat hemophilia A

Neuroscience startup Neumora files for IPO

leisure time

NFL doctors' conflicts of interest could endanger players, report says

Paxlovid rebound happens. Why and to whom are still a mystery

Diversity in medical illustrations gets boost from Chidiebere Ibe

CDC advisory panel says seniors 'may' get RSV vaccine

Feed a cold, starve a fever? Here’s what science says

CDC advisory panel says seniors 'may' get RSV vaccine

knowledge

focus

focus

entertainment